Boc-O-methyl-L-homoserine.DCHA salt

Boc-O-methyl-L-homoserine.DCHA salt is a protected L-homoserine derivative designed for peptide and peptidomimetic synthesis workflows, featuring a Boc-protected amino group and an O-methyl-protected side-chain hydroxyl that is masked as an ether. The DCHA salt form is used to improve handling and facilitate consistent formulation during downstream coupling steps. This reagent is typically selected when a homoserine-derived residue with controlled functional-group protection is required for segment assembly and subsequent deprotection strategies.

1. Solid-Phase Peptide Synthesis

Boc-O-methyl-L-homoserine.DCHA salt is used as a protected amino acid building block for solid-phase peptide synthesis where a homoserine-derived side chain must remain protected through the coupling and washing cycles. Peptide synthesis groups that build peptide libraries or longer peptide segments rely on the Boc-protected amine and the O-methyl side-chain protection to reduce undesired side reactions during assembly, enabling cleaner coupling sequences and more predictable purification profiles. The DCHA salt form is commonly chosen in research and custom synthesis settings to support reproducible reagent weighing, dissolution behavior, and consistent delivery to automated or semi-automated peptide synthesis workflows.

2. Peptide Segment Coupling

Boc-O-methyl-L-homoserine.DCHA salt supports solution-phase or fragment-based peptide assembly when homoserine functionality needs to be masked until the final deprotection stage. Medicinal chemistry teams and peptide manufacturing groups use this protected residue to construct peptide intermediates with controlled orthogonality, allowing the homoserine side-chain to remain non-reactive during segment condensation and subsequent transformations. By selecting this specific protection pattern, developers can better manage chemoselectivity across multi-step coupling schedules, particularly when the target sequence contains additional nucleophilic or base-sensitive groups that would otherwise compete with coupling reagents.

3. Peptidomimetic Intermediate Development

Boc-O-methyl-L-homoserine.DCHA salt is also used as a protected chiral intermediate for preparing homoserine-based peptidomimetic scaffolds and related building blocks in pharmaceutical intermediate development. Organic synthesis teams incorporate this residue into constrained or functionalized analogs where the side-chain hydroxyl must be protected as an ether during elaboration of neighboring stereocenters and backbone modifications. The DCHA salt form is frequently favored in industrial and scale-up contexts for practical handling of the protected amino acid, supporting reliable batch preparation for downstream derivatization into specialized peptide-like structures.

1. The effect of B-type allatostatin neuropeptides on crosstalk between the insect immune response and cold tolerance

2. cRGD-functionalized, DOX-conjugated, and 64Cu-labeled superparamagnetic iron oxide nanoparticles for targeted anticancer drug delivery and PET/MR imaging

3. Genetic, cellular, and structural characterization of the membrane potential-dependent cell-penetrating peptide translocation pore

4. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

5. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes